亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

PF728 COMPARISON OF ALLOPURINOL AND FEBUXOSTAT FOR PREVENTION OF HYPERURICEMIA AND TUMOR LYSIS SYNDROME IN ACUTE LEUKEMIAS

别嘌呤醇 高尿酸血症 肿瘤溶解综合征 医学 非布索坦 尿酸 Rasburicase酶 黄嘌呤氧化酶 胃肠病学 内科学 化疗 药理学 生物化学 化学 酶
作者
Sumeet Mirgh,Manoranjan Mahapatra,Tulika Seth,Rishi Dhawan,Mukul Aggarwal,Renu Saxena,Hara Prasad Pati,S. Tyagi
出处
期刊:HemaSphere [Wolters Kluwer]
卷期号:3 (S1): 318-319
标识
DOI:10.1097/01.hs9.0000561196.66352.25
摘要

Background: Serum uric acid control is of prime importance in prevention of tumor lysis syndrome. Each mg/dl rise in uric acid increases the risk of tumor lysis syndrome and renal events by 1.75‐fold and 2.25‐fold respectively. We compared two xanthine oxidase inhibitors ‐ allopurinol and febuxostat as hypouricemic agents in patients of acute leukemias. Aims: The aims of the study were to assess the change in serum uric acid levels from baseline to day+7 after chemotherapy and to determine the incidence of tumor lysis syndrome in both groups. Methods: In this single‐institution prospective cohort study (study period – January2017 – July2018), acute leukemia patients scheduled to receive induction chemotherapy were administered either allopurinol or febuxostat, starting atleast 1 day prior to chemotherapy till 8 days after chemotherapy. Daily dose for Allopurinol was 300 mg/m2 and for febuxostat, it was 80 mg (10 mg daily for children < = 15years). Patients with baseline uric acid level >8 mg/dl, presence of hepatic or renal dysfunction and history of receiving rasburicase were excluded. The primary objective was to compare both the drugs in terms of decrease in serum uric acid levels analysed by area under curve (AUC) for a 7‐day treatment period. Results: A total of 120 patients (60 patients in each group) were recruited. Both groups were comparable in terms of gender, age, diagnosis and baseline uric acid levels. Mean AUC of serum uric acid day1–8 was 457.68 ± 27.55 mg‐h/dL versus 532.32 ± 34.39 mg‐h/dL, in favour of febuxostat [P = 0.09].The difference between the two study drugs was statistically significant for febuxostat on day+3 [ P < 0.05] (Figure 1).10% (n = 6) patients on allopurinol developed TLS compared to 3.33% (n = 2) patients on febuxostat. The Odds ratio for tumor lysis syndrome in patients receiving febuxostat relative to those receiving allopurinol was 0.33. Drug related adverse events were 38.33% (n = 23) in allopurinol group, in contrast to 11.66% (n = 7) in the febuxostat group. Most common adverse event in allopurinol arm was gastrointestinal, whereas in febuxostat arm, it was asymptomatic transaminitis. Cutaneous reactions (6.6%;n = 4) were noticed only in allopurinol group. Summary/Conclusion: Irrespective of type of leukemia, lactate dehydrogenase levels, leukocyte counts and baseline uric acid levels, febuxostat in comparison to allopurinol, performed non‐inferior with respect to its uric acid lowering efficacy. It had relatively lesser risk of tumor lysis syndrome with a trend towards significance and a better safety profile. image

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
娜娜米发布了新的文献求助80
1秒前
沧海云帆发布了新的文献求助10
3秒前
4秒前
6秒前
7秒前
pzh完成签到 ,获得积分10
9秒前
11秒前
14秒前
21秒前
笨笨的青完成签到 ,获得积分10
21秒前
冷酷的飞绿完成签到 ,获得积分10
21秒前
Crssss的应助被优雅的黄豆采纳,获得10
21秒前
21秒前
小二郎的应助被娜娜米采纳,获得10
23秒前
张唤发布了新的文献求助10
25秒前
尊敬的之瑶完成签到,获得积分20
25秒前
科研通AI2S的应助被葵花街37号采纳,获得10
29秒前
科研通AI65的应助被萧雨墨采纳,获得10
32秒前
雪白的龙猫完成签到 ,获得积分10
35秒前
武陵人完成签到 ,获得积分10
36秒前
36秒前
嘻嘻哈哈的应助被张唤采纳,获得10
37秒前
花海发布了新的文献求助100
37秒前
45秒前
47秒前
CZ88完成签到 ,获得积分10
47秒前
友好的子轩完成签到,获得积分10
49秒前
谢志超发布了新的文献求助10
51秒前
机灵的鼠标完成签到,获得积分10
52秒前
学术肺雾完成签到 ,获得积分10
52秒前
玫瑰花茶完成签到 ,获得积分10
52秒前
萧雨墨发布了新的文献求助30
53秒前
1分钟前
隐形初雪完成签到 ,获得积分10
1分钟前
情怀的应助被SSUABWB采纳,获得10
1分钟前
1分钟前
DD完成签到 ,获得积分10
1分钟前
酷波er的应助被beyfish采纳,获得10
1分钟前
L8完成签到,获得积分10
1分钟前
one完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190049
求助须知:如何正确求助?哪些是违规求助? 9577165
关于积分的说明 21851842
捐赠科研通 7788131
什么是DOI,文献DOI怎么找? 3436227
关于科研通互助平台的介绍 2559910
邀请新用户注册赠送积分活动 2482768